Ignite Creation Date:
2024-05-06 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05696548
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-21
First Post:
2023-01-13
Brief Title:
Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer NAVIGATION
Sponsor:
National Cancer Center Hospital East
Organization:
National Cancer Center Hospital East
Organization Data
Organization:
National Cancer Center Hospital East
Class:
OTHER
Study ID:
YCU18001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Center Hospital East
Lead Sponsor Class:
OTHER
Responsible Party:
Makoto Tahara
Responsible Party Title:
Chief Department of Head and Neck Medical Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Cancer Center Hospital East
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ono Pharmaceutical Co Ltd | INDUSTRY |